The pandemic has highlighted the United States’ dependence on China for research animals, reviving calls for a “strategic monkey reserve.”
The Biden administration has secured more coronavirus vaccines, but the president struck a cautious tone about logistical issues that could keep some Americans from being vaccinated.
He helped devise a successful chemotherapy regimen for childhood leukemia, which had long been a death sentence.
Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.
In pleas for more money from Capitol Hill, the advisers said the United States was still facing shortages of protective gear and other supplies.
The money went to unrelated government activities like the removal of office furniture, news subscriptions and legal expenses.
The N.I.H. and Moderna are examining whether doses of Moderna’s coronavirus vaccine can be halved to double the supply, while scientists look for other ways to extend availability.
As the U.S. confronted a new wave of infection and death through the summer and fall, the president’s approach to the pandemic came down to a single question: What would it mean for him?
Giving anticoagulants to hospitalized Covid-19 patients is routine. But high doses may sometimes do more harm than good, a safety board finds.
Heroic work went into the development of the coronavirus vaccines. But that doesn’t mean this industry deserves your affection.
The positive review likely ensures that the F.D.A. will grant emergency authorization for a second coronavirus vaccine this week for millions of Americans.
Within days, all three countries could be giving the Pfizer-BioNTech vaccine, but they have varying strategies and challenges. The U.S. plan, working through the states, is the least centralized.
Come spring, Americans may have their choice of several so-so coronavirus vaccines — with no way of knowing which one is best.
Dr. Rick Bright, who said he was demoted at the health department for blowing the whistle on a politicized coronavirus response, remains concerned about White House interference.
Activists and some congressional lawmakers are demanding that the N.I.H. reconsider its refusal to move 39 chimpanzees from a research center to a sanctuary.
A managing editor of the right-wing website RedState appeared to attack Dr. Anthony S. Fauci and spread misinformation about the coronavirus pandemic while working for Dr. Fauci’s agency.
A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
Six months into the pandemic and with no coherent national testing strategy, the Trump administration is encouraging private development of an array of faster and cheaper techniques.
Here’s how: Follow Britain’s example.
Stephen Hahn made misleading remarks about a coronavirus treatment. How did that happen?
Researchers are testing an experimental drug to halt sudden outbreaks. The trial may bring a new type of treatment for the virus.
A new advisory board, appointed by the Trump administration, recommended that the health secretary reject funding for virtually every fetal tissue research project it considered.
Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Public health experts say delays in testing continue to hinder attempts to track and contain the spread of disease.
The roots of the nation’s current inability to control the pandemic can be traced to mid-April, when the White House embraced overly rosy projections to proclaim victory and move on.
As the Trump White House attacks the government’s top infectious disease expert, “What’s happening to Dr. Fauci?” has become an urgent topic in Washington and in science and medical circles.
The visit underscored a reality for both the president and his most prominent coronavirus adviser: They are stuck with each other.
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Scammers are out to get personal information that could lead to identity theft.
Fossils and modern DNA show the ancient roots of Arctic sled dogs.
The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled.
The shift, quietly disclosed on a government website, highlights how the Trump administration is favoring development of vaccines over treatments for the sickest patients.
Garrison Kenneth Courtney pretended to be a C.I.A. officer to bilk companies.
The technology was old, the data poor, the bureaucracy slow, the guidance confusing, the administration not in agreement. The coronavirus shook the world’s premier health agency, creating a loss of confidence and hampering the U.S. response to the crisis.
Researchers whose canceled U.S. grant caused an outcry from other scientists urge preventive monitoring of viruses in southwestern China.
It’s the best way to get the resources and health system we need.
Acting before or very soon after an infection is the best way to handle most acute viral diseases. Why aren’t we focusing on that with Covid-19?
A group of 77 Nobel laureates wants the U.S. government to review a grant cancellation for research in China directly related to preventing pandemics.
Sobering lessons from the history of the polio vaccine.
A series of animal experiments may point the way to an effective human vaccine, scientists said.
The case was the latest example of the Justice Department’s efforts to combat Chinese influence on American campuses.
The administration kneecaps experts as the coronavirus rages.
The agency had come under fire from members of Congress and other groups for allowing dozens of wildly inaccurate tests to proliferate without oversight.
Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial.
The president’s Covid-19 response has extended the administration’s longstanding practice of undermining scientific expertise for political purposes.
The tests are not reliable enough to guide policy on lockdowns and reopenings, experts said. But they can help model the spread of the virus.
Rick Bright was abruptly dismissed this week as the director of the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority.
Several methods are effective at killing the new coronavirus on N95 masks — primary protective gear for health care workers — for two or three rounds of use.
Even though it can make infections worse, it also may be able to keep the immune system from overreacting.